UMIN-CTR Clinical Trial

Recruitment status Completed
Unique ID issued by UMIN UMIN000020247
Receipt No. R000023377
Official scientific title of the study Effectiveness of glycolic acid for the treatment of the pigmented lesion; Prospective, randomized, and split-face comparative study
Date of disclosure of the study information 2015/12/17
Last modified on 2018/12/14 (Ver. 3)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Effectiveness of glycolic acid for the treatment of the pigmented lesion; Prospective, randomized, and split-face comparative study
Title of the study (Brief title) Effectiveness of glycolic acid for the treatment study
Region
Japan

Condition
Condition pigmented lesion
Classification by specialty
Dermatology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 The effectiveness of glycolic acid for the pigmented lesion
Basic objectives2 Safety,Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Clinical study
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Single arm
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Self control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 1
Purpose of intervention Treatment
Type of intervention
Other
Interventions/Control_1 The essectiveness of the Glycolic acid lotion
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria The pigmented lesion on the face
Key exclusion criteria The patients have the severe disease
Target sample size 30

Research contact person
Name of lead principal investigator Chikako Kaminaka
Organization wakayama Medical University
Division name Department of Dermatology
Address 811-1KimiideraWakayama
TEL 073-441-0661
Email kamikami@wakayama-med.ac.jp

Public contact
Name of contact person Chikako Kaminaka
Organization Wakayama Medical University
Division name Department of Dermatology
Address 811-1KimiideraWakayama
TEL 073-441-0661
Homepage URL
Email kamikami@wakayama-med.ac.jp

Sponsor
Institute Wakayama Medical University
Institute
Department

Funding Source
Organization JMEC, Co., Ltd.
Organization
Division
Category of Funding Organization Other
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2015 Year 12 Month 17 Day

Progress
Recruitment status Completed
Date of protocol fixation
2015 Year 11 Month 01 Day
Anticipated trial start date
2015 Year 12 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Published
URL releasing results
Results
Other related information

Management information
Registered date
2015 Year 12 Month 17 Day
Last modified on
2018 Year 12 Month 14 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023377